Zurueck zur Suche

Reporte zur Charge UT8129KA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

5Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
KS 2 SC 1 TX 1 TN 1

VAERS 2725369

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8129KA

mild
Staat
KS
Alter
54,0
Geschlecht
M
Eingang
19.12.2023
Impfdatum
04.12.2023
Beginn
05.12.2023
Tage bis Beginn
1,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site pain Musculoskeletal stiffness Swelling

Symptomtext

On 12/19/2023, he was still having muscle aches and pain at the site, could not turn his head, and some swelling was noted on the right side of the body. (Per phone conversation with this nurse)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none low hemoglobin and potassium
Vorgeschichte
high bp, anxiety
Andere Medikamente
Potassium, iron, multivitamins, omega-3 fish oil, alprazalam, losartin, carpeilol, sartrane, amlodipene, hctz, atorvasatin, baby aspirin.
Allergien
Shell fish
Vorherige Impfungen
-

VAERS 2722963

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8129KA

mild
Staat
SC
Alter
46,0
Geschlecht
M
Eingang
11.12.2023
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exposure via skin contact Injection site discharge No adverse event Underdose

Symptomtext

they are not sure if half of the medication leaked out or less since it leaked out of the patient's arm; during the injection half of the medication was administered, and half of the medication spilled out with no reported adverse event; during the injection half of the medication was administered, and half of the medication spilled out with no reported adverse event; Initial information received on 04-Dec-2023 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 46-year-old male patient and the reporter stated that they are not sure if half of the medication leaked out or less since it leaked out of the patient's arm after receiving influenza quadrival A-B vaccine [Fluzone Quadrivalent] and during the injection half of the medication was administered, and half of the medication spilled out with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided. On an unknown date, the patient received an unknown dose of suspect influenza quadrival A-B vaccine, Suspension for injection (strength: unknown) (lot: UT8129KA, expiry date: 30-Jun-2024) via unknown route in unknown administration site for Immunization. On an unknown date the patient developed a non-serious they are not sure if half of the medication leaked out or less since it leaked out of the patient's arm (exposure via skin contact) and during the injection half of the medication was administered, and half of the medication spilled out with no reported adverse event (accidental exposure to product) and (incorrect dose administered) (unknown latency). Action taken: not applicable. It was not reported if the patient received a corrective treatment for the event. Outcome: Unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site discharge
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2708300

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8129KA

mild
Staat
TX
Alter
2,0
Geschlecht
M
Eingang
01.11.2023
Impfdatum
30.10.2023
Beginn
31.10.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site swelling

Symptomtext

Redness and swelling at injection site, got bigger throughout the day

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2702634

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8129KA

mild
Staat
KS
Alter
13,0
Geschlecht
F
Eingang
26.10.2023
Impfdatum
24.10.2023
Beginn
24.10.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Eye swelling Feeling abnormal Lip swelling Rash

Symptomtext

Patient went to bed with no issues Tuesday evening. When she awoke Wednesday morning, she complained of not feeling good. Parent states she had swelling to her eyes and lips with a rash to the left side of her face and neck. She denies having any trouble breathing or swallowing. Administered Benadryl 50mg PO BID Wednesday, and 25mg PO x1 today. Swelling and rash had improved upon discussion with mom.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
ADHD, Anxiety
Andere Medikamente
Adderall ER25mg PO QD, Lexapro 10mg oral QD, Apri 1 tab QD
Allergien
None
Vorherige Impfungen
-

VAERS 2722176

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UT8129KA

gering
Staat
TN
Alter
20,0
Geschlecht
F
Eingang
08.12.2023
Impfdatum
15.11.2023
Beginn
15.11.2023
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exposure during pregnancy No adverse event Pregnancy test positive

Symptomtext

Patient was given HPV vaccine but had a positive pregnancy test. VAERS report submitted due to clinical indications on package insert for HPV vaccine. No Adverse events or reactions occurred for this patient, to the knowledge of the healthcare providers.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Exposure during pregnancy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None Reported.
Vorgeschichte
None Reported.
Andere Medikamente
None Reported.
Allergien
No Known Allergies.
Vorherige Impfungen
-